Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes.
about
Oral Hypoglycemic Agents in pregnancy: An UpdateBirth defects in pregestational diabetes: Defect range, glycemic threshold and pathogenesisType 2 diabetes in pregnancy: exposing deceptive appearances.Pregnancy in women with Type 2 diabetes: 12 years outcome data 1990-2002.Oxidative stress during diabetic pregnancy disrupts cardiac neural crest migration and causes outflow tract defects.Diabetes trends among delivery hospitalizations in the U.S., 1994-2004.Evaluation of neonatally-induced mild diabetes in rats: Maternal and fetal repercussionsPathogenesis of diabetes-induced congenital malformations.Increased DNA methyltransferase 3b (Dnmt3b)-mediated CpG island methylation stimulated by oxidative stress inhibits expression of a gene required for neural tube and neural crest development in diabetic pregnancy.Diabetes mellitus and birth defects.What neonatal complications should the pediatrician be aware of in case of maternal gestational diabetes?Advances in understanding the molecular causes of diabetes-induced birth defects.Descriptive epidemiology of non-syndromic complete atrioventricular canal defects.Type 2 diabetes in pregnancy: a wolf in sheep's clothing.Heat shock protein production and immunity and altered fetal development in diabetic pregnant rats.Hyperglycemia slows embryonic growth and suppresses cell cycle via cyclin D1 and p21.Etiology, pathogenesis and prevention of neural tube defects.Risk factors associated with birth defects at a tertiary care center in PakistanChallenges in understanding diabetic embryopathy.The status of diabetic embryopathy.Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus-associated birth defects.Similar adverse pregnancy outcome in native and nonnative dutch women with pregestational type 2 diabetes: a multicentre retrospective study.Diabetes and apoptosis: neural crest cells and neural tube.Anti-diabetic drug utilization of pregnant diabetic women in us managed care.Management of Type 2 diabetes and pregnancy.Can pregnant diabetics be treated with glyburide?Preconception care for women with diabetes and prevention of major congenital malformations.Pregnancy and Infants' Outcome: Nutritional and Metabolic Implications.Poly(ADP-ribosylated) proteins in mononuclear cells from patients with type 2 diabetes identified by proteomic studies.Neonatal outcomes following planned preterm delivery in diabetic mothers.Epidemiology of congenital anomalies of the central nervous system in children in Enugu, Nigeria: A retrospective study.Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012.Posterior fossa infected dermoid with congenital heart disease: A novel hypothesis of an unusual association.Maternal influenza-like illness, medication use during pregnancy and risk of congenital heart defects in offspring.Intrauterine growth retardation in experimental diabetes: possible role of the placenta.Induction of embryonic dysmorphogenesis by high glucose concentration, disturbed inositol metabolism, and inhibited protein kinase C activity.In human gestational diabetes mellitus congenital malformations are related to pre-pregnancy body mass index and to severity of diabetes.Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes.Glyburide compared to insulin for the treatment of gestational diabetes mellitus: a cost analysis.[Diabetes in hospital deliveries in public and private health system hospitals].
P2860
Q26851879-27247C0D-DA37-4EEB-A352-BEF46292FEA3Q26991573-D7454F97-3CAB-44AE-A98C-5EFD0DA397BFQ30367945-6301B7B6-F31C-4680-BBE3-3973C12DE8ADQ30819235-F50805F9-6588-466D-A270-560FA212E922Q33750553-39A4486D-AF32-4C1B-BD24-E98D20E47121Q33751491-3F2411BC-BF8B-4AED-980D-455624F494D1Q33997909-8A7AF29A-39D3-48F9-82DF-92A333C77CC5Q34091873-45082A9B-79E2-4723-8464-1147971503D0Q34227874-0305266C-663C-40BB-9B8E-C44B61193A3FQ34803469-38F65EEF-CB62-4177-9E71-87196A94B067Q35691385-7223A46A-8FFE-4B3B-ABF0-26BE9B39BBD3Q36319750-4F63EE66-F96B-4A80-8F88-DA2037328086Q36350174-B2AEE1FF-C87A-42FE-9B64-915219813B89Q36364030-CDE23E0F-FDC1-4D01-949C-002CF6478AB7Q36428134-37DE43CB-5CB0-453A-BD46-FD94FC357AE1Q36477231-72BB27A2-11EE-42F6-A4D4-4750FAAA496AQ36491874-FC2A7E1F-EA23-4EF5-935D-959B47F0C0D7Q36552218-99477FD6-8F37-4493-AA59-FB0839442A25Q36975427-0806EF7B-82EA-4CF8-9325-C87F72EDA5ECQ36986969-4CDC8847-8A73-4607-A2DC-F45D1062926CQ37025015-1FBA09C7-889B-4E73-B1CE-16D009AE32D5Q37322454-56183489-76D8-4C5D-BE68-909899BF9645Q37351323-EE8057A9-5A0F-4D1F-B5C0-8607E3B4E2FBQ37502324-5EE01C13-952F-4F81-B93C-1E77F2816ADBQ37608444-675296EE-8D1B-4E7A-9857-177AE966C2A5Q37622980-C66033CA-ACC9-44F5-A328-CF02266DD137Q37796716-3119BC2A-2F9A-4D39-ADED-80AF32B7A317Q38195866-D7ED660E-9C4F-407E-8E12-4DEE534E9F95Q38728370-3296C307-2319-4AD7-8963-1C74C41A8DDAQ38914528-B21DE20D-2FE4-4545-880B-FC2B7AD6BD79Q38934225-6BC51519-813E-47B3-B68F-E93EA06B7E39Q38961311-5BB01E42-C7D5-4A79-B320-760A3BA0C1FBQ40914547-66806302-A2AA-41C0-9022-BF65ACCEE3C3Q42247538-B5613767-1528-4CC4-AA84-0DA2F108AD3DQ42518303-5A687C86-516A-474D-A776-779E5AA83566Q43587199-F36C5300-2753-4EBC-9238-8D3F595F4774Q43620468-AC4DD6C8-BB33-4FFD-BEF0-1B8CD5E4172EQ43953703-61ABFB0A-A0B5-4030-B1C4-0DE87E27F1CCQ44040184-EB3EC5FF-69D2-4712-9990-2DBEC7B6E63BQ44373987-2BBF0C5B-4ADC-4C5B-9D13-5460927A8B22
P2860
Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Patterns of congenital anomali ...... pe 2 and gestational diabetes.
@en
type
label
Patterns of congenital anomali ...... pe 2 and gestational diabetes.
@en
prefLabel
Patterns of congenital anomali ...... pe 2 and gestational diabetes.
@en
P2093
P1476
Patterns of congenital anomali ...... pe 2 and gestational diabetes.
@en
P2093
Buchanan TA
Schaefer-Graf UM
Songster G
P304
P356
10.1016/S0002-9378(00)70217-1
P407
P577
2000-02-01T00:00:00Z